Syndax Pharmaceuticals (NasdaqGS:SNDX) Q4 2025 Earnings call February 26, 2026 04:30 PM ET Company ParticipantsClara Dong - VP of Equity Research in BiotechnologyCorinne Johnson - Managing DirectorDavid Dai - DirectorJason Zemansky - VP of Equity ResearchJosh Bowen - DirectorKeith Goldan - CFOMichael Metzger - CEONick Botwood - Head of R&D and Chief Medical OfficerPriyanka Grover - VP of Biotechnology Equity ResearchSharon Klahre - Head of Investor RelationsStephen Willey - Managing DirectorSteve Closter - ...

Fourth Quarter and Full Year 2025 Financial Results February 26, 2026 Forward-looking statements disclosure This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "may," "will," "expect," "plan," "anticipate" and similar expressions (as well as other words or expressions referencing future events, progress, timing or circumstances) are intended to identify forward-looking statements. All statements other than statements ...